Lunai Bioworks Inc. (NASDAQ:LNAI) said it has signed a binding agreement to purchase blood-brain barrier delivery technology ...

Delonix Bioworks, a clinical-stage biotechnology company pioneering genetically engineered bacterial vaccines, today announced the initiation of first-in-human (FIH) dosing in a Phase 1 clinical trial ...

Shares of Lunai Bioworks Inc. LNAI are soaring Thursday after the company announced that it will acquire blood-brain barrier ...

Lunai Bioworks (NASDAQ: LNAI), through its wholly owned subsidiary BioSymetrics, today announced the formation of a national ...

AI life sciences stock Lunai Bioworks (NASDAQ: LNAI) surges after $20 million CNS drug delivery acquisition, strengthening ...

Ginkgo Bioworks is a cell programming specialist that has partnered with many big companies. It is in a very early stage, but has a lot of promising opportunities in the long run. A big part of the ...

Could Ginkgo Bioworks Holdings (NYSE: DNA) one day be part of the healthcare sector's version of the "Magnificent Seven" group of high-performing stocks? It's more likely than you think. The ...

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares continue to trade higher after rising nearly 10% on Tuesday. Here’s a look at what’s going on. What To Know: Ginkgo Bioworks shares appear to be getting ...

Some analysts and portfolio managers see a bright future for Ginkgo Bioworks. Each collaborator that signs on is a vote of confidence in its future success. However, keep in mind that the biofoundry ...